financetom
Business
financetom
/
Business
/
Pipeline Powerhouse Plains All American Beats On Earnings with Flat EBITDA: Details
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pipeline Powerhouse Plains All American Beats On Earnings with Flat EBITDA: Details
May 3, 2024 8:31 AM

Plains All American Pipeline, L.P. ( PAA ) shares are trading higher after it reported revenue of $11.995 billion, missing the consensus of $12.977 billion.

The company reported an operating income of $370 million, compared to $473 million a year ago. The adjusted EBITDA attributable to PAA remained broadly flat Y/Y at $718 million.

The Crude Oil Segment Adjusted EBITDA rose 7% Y/Y to $553 million, led by higher tariff volumes on the pipelines, tariff escalations and contributions from acquisitions.

NGL Segment Adjusted EBITDA decreased 17% Y/Y to $159 million, due to lower realized frac spreads. PAA generated an adjusted free cash flow of $262 million in the quarter.

Adjusted earnings per common unit was $0.41 (flat Y/Y), beating the consensus of $0.39.

Also Read: Plains All American Pipeline Gears Up For Q1 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

The company increased annualized common distribution by $0.20 to $1.27 per unit (an increase of 19% Y/Y, paid in February).

Outlook: The company expects underlying growth in the business and contributions from efficient growth investments to offset lower contracted rates, resulting in broadly flat adjusted EBITDA in 2026 vs. 2024 guidance for the Crude Oil segment.

“Separately, we successfully extended the duration of our Permian long-haul portfolio, including Cactus I. This represents a major milestone and provides greater clarity on the outlook for our long-haul assets. Better visibility around re-contracting combined with our disciplined operational and financial performance should provide investors with greater confidence in the outlook for the business and our ability to continue generating significant free cash flow for years to come,” commented Willie Chiang, Chairman and CEO.

Investors can gain exposure to the stock via InfraCap MLP ETF ( AMZA ) and Alerian MLP ETF ( AMLP ) .

Price Action: PAA shares are up 1.68% at $17.52 at the last check Friday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Radio broadcaster iHeartMedia Q3 revenue beats estimates, helped by digital audio growth
Radio broadcaster iHeartMedia Q3 revenue beats estimates, helped by digital audio growth
Nov 10, 2025
Overview * iHeartMedia Q3 revenue down 1.1% (Excluding Q3 PoliticalRevenue, Q3Revenueup 2.8%), beats analyst expectations * Adjusted EBITDA for Q3 beats consensus, remaining flat year-over-year * Company reports GAAP operating loss due to $209 mln non-cash impairment charges Outlook * iHeartMedia expects Q4 consolidated revenue to decline low-single digits * Q4 Consolidated Revenue excluding the impact of Political expected to...
CarParts.com Q3 sales miss estimates
CarParts.com Q3 sales miss estimates
Nov 10, 2025
Overview * CarParts.com ( PRTS ) Q3 net sales fell 12% to $127.8 mln, missing analyst expectations * The eCommerce provider ofautomotiveparts and accessories posted Net loss for Q3 of $10.9 mln, vs $10.0 mln loss last year * Company closed a $35.7 mln strategic investment to enhance logistics and product range Outlook * CarParts.com ( PRTS ) expects to...
CoreWeave beats third-quarter revenue estimates on AI computing boom
CoreWeave beats third-quarter revenue estimates on AI computing boom
Nov 10, 2025
Nov 10 (Reuters) - AI cloud provider CoreWeave ( CRWV ) beat Wall Street estimates for third-quarter revenue on Monday, benefiting from surging demand for its computing infrastructure that powers artificial intelligence workloads. The company reported revenue of $1.36 billion for the third quarter, compared with analysts' average estimate of $1.29 billion, according to data compiled by LSEG. ...
Clinical-stage biotech Celldex's Q3 net loss widens to $67 mln
Clinical-stage biotech Celldex's Q3 net loss widens to $67 mln
Nov 10, 2025
Overview * Celldex Q3 net loss widens to $67 mln, below analysts' expectations * Company reports zero revenue in Q3, down from $3.2 mln in prior year * Positive Phase 2 data for barzolvolimab in multiple indications Outlook * Celldex plans to initiate a global Phase 3 study for ColdU and SD in December 2025 * Celldex expects multiple data...
Copyright 2023-2026 - www.financetom.com All Rights Reserved